-- Bayer Patent Families Expand Quantum Materials' Advanced
Material Offerings, Reinforce Intellectual Property Protection of
Automated Quantum Dot Manufacturing Processes and Enhance Quantum
Dot Solar Cell IP to Drive Future Development, Partnerships and
Revenue
SAN MARCOS, Texas, Aug. 20, 2014 /PRNewswire/ -- Quantum
Materials Corporation (OTCQB:QTMM) today announced the purchase of
five diverse sets of patent families from Bayer Technology
Services GmbH, the global technological backbone and major
innovation driver for Bayer AG of Leverkusen, Germany.
Logo - http://photos.prnewswire.com/prnh/20140619/119488
The patents acquired provide broad intellectual property
protection for advances Quantum Materials has achieved in
economical high-volume quantum dot (QD) manufacturing. In addition,
the Bayer patents cover volume production technology for heavy
metal-free (HMF) quantum dots and nano-particles; increasing
quantum yields for HMF quantum dots; and hybrid organic quantum dot
solar cell (QDSC) production as well as a surface modification
process for increased efficiency of high performance solar cells
and printed electronics. The patent families were acquired through
a cash purchase agreement and financial details will remain
private.
"We acquired these patents to not only expand our technology
portfolio in heavy metal-free and QDSC production, but also to
protect the advances we have made to date in the volume
manufacturing of nanoparticles, including quantum dots," said
Stephen Squires, Quantum Materials
CEO and president. "Bayer is a research pioneer in the
nanotech and QD fields and these early filings were awarded with
broad claims. It will be very difficult for competitors to produce
materials in volume similar to ours without breaching our
patents."
"Bayer Technology Services has been successfully working in the
field of nanotechnology for more than 30 years . We are very happy
that Quantum Materials is also using our patents to invest into new
markets Bayer is not focusing on," adds Dr. Guenter Bachlechner, Head of Technology
Development and Senior Vice President of Bayer Technology Services
GmbH.
The quantum dot-related patents extend Quantum Materials'
ability to synthesize numerous heavy metal-free organic periodic
table groups in addition to its own inorganic Group II-VI
composites. The company intends to incorporate each patent into its
advanced production processes, including high yield InP/ZnS
nanocrystals, a heavily researched QD in high demand in
optoelectronics.
The solar-related patents describe the fundamental design of
quantum dot solar cells and processes for optimizing quantum dots
for solar and other printed electronics applications. The solar
patents enhance Quantum Material's licensed patent on printing OLED
and QD solar cells and other printed electronic devices by
gravure or high-speed roll-to-roll.
David Doderer, Quantum Materials
VP of Research and Development, added, "The heavy metal-free
organic nanomaterials expand our high performance product
offerings, and the automated processes will bring down their cost
so manufacturers can begin planning adoption into real products at
price points that expand market penetration of quantum dot
technologies significantly. Combining the solar patents with our
automated volume QD production process opens the door for us to
establish joint ventures for Quantum Dot Solar Cell (QDSC) pilot
plants worldwide."
About Bayer Technology Services
Bayer Technology
Services offers fully-integrated solutions along the life cycle of
chemical/pharmaceutical plants – from development through
engineering and construction to process optimization for existing
plants. The Bayer subsidiary employs nearly 2,300 people worldwide
at its headquarters in Leverkusen and other German locations, as
well as in regional offices in Belgium, Brazil, Canada, India, Mexico, the People's
Republic of China, Russia,
Singapore and the United States. 2013 sales totaled
approximately EUR 470 million.
Additional information about Bayer Technology Services is available
at www.bayertechnology.com.
About Quantum Materials Corp.
Quantum Materials Corp.
develops and manufactures Tetrapod Quantum Dots for use in medical,
display, solar energy and lighting applications through its
patent-pending volume production process. QMC's volume
manufacturing methods enable consistent quality and scalable cost
reductions to drive innovative discovery to commercial success.
(www.qmcdots.com). Wholly-owned subsidiary Solterra Renewable
Technologies develops sustainable solar technology by replacing
silicon wafer-based solar cells with high-production, low-cost,
efficient and flexible thin-film quantum dot solar
cells. (http://solterrarenewable.com)
Safe Harbor statement under the Private Securities Litigation
Reform Act of 1995
This press release contains
forward-looking statements that involve risks and uncertainties
concerning business, products, and financial results. Actual
results may differ materially from the results predicted. More
information about potential risk factors that could affect our
business, products, and financial results are included in our
annual report and in reports subsequently filed with the Securities
and Exchange Commission ("SEC"). All documents are available
through the SEC's EDGAR System at http://www.sec.gov/ or
www.QMCdots.com. We hereby disclaim any obligation to publicly
update the information provided above, including forward-looking
statements, to reflect subsequent events or circumstances.
Contact:
Art Lamstein
Director of Marketing
Quantum Materials Corp.
+1.415.609.4969
artlamstein@QMCdots.com
Media:
Rich Schineller
+1.941.780.8100
rich@prmgt.com
Dr. Arnold Rajathurai
Head of Corporate Communications
Bayer Technology Services GmbH
arnold.rajathurai@bayer.com